Vita Coco Company, Inc.·4

Apr 30, 4:15 PM ET

Roper Martin 4

4 · Vita Coco Company, Inc. · Filed Apr 30, 2026

Research Summary

AI-generated summary of this filing

Updated

Vita Coco (COCO) CEO Roper Exercises Options, Sells Shares

What Happened

  • Roper Martin, Chief Executive Officer of Vita Coco (COCO), exercised stock options and immediately sold the acquired shares. On 2026-04-28 he exercised 25,000 options at $10.18 (reported cost $254,450) and sold 25,000 shares in the open market for $51.13 (proceeds $1,278,250). On 2026-04-29 he exercised 20,544 options at $10.18 (reported cost $209,097) and sold 20,544 shares in the open market for $59.35 (proceeds $1,219,245). Total exercise cost reported = $463,547; total gross sale proceeds reported ≈ $2,497,495.

Key Details

  • Transaction dates: 2026-04-28 (25,000 shares) and 2026-04-29 (20,544 shares).
  • Exercise price(s): $10.18 per share (two exercises).
  • Sale prices reported: weighted averages $51.13 and $59.35; filing notes some trades ranged $56.68–$60.50.
  • Total shares involved: 45,544 shares exercised and sold.
  • Notable footnotes: sales were effected pursuant to a Rule 10b5‑1 trading plan (F1); one sale price is a weighted average over multiple trades (F2); the filing records derivative dispositions at $0.00 associated with the exercises (as reported on the Form 4); the option(s) exercised are described as exercisable/vested in the filing (see F6).
  • Shares owned after transaction: not specified in the provided extract.
  • Timeliness: filing date 2026-04-30 for transactions on 4/28–4/29; no late-filing flag noted in the provided data.

Context

  • This pattern — exercising options and selling the resulting shares immediately — is commonly a cashless exercise and sale; the Form 4 shows both the option exercises and the subsequent open-market sales. Because the sales were made under a pre-established Rule 10b5‑1 plan, they appear to follow a pre-planned schedule rather than ad hoc trading.
  • Facts only: the filing documents the mechanics and proceeds; it does not state management’s motives or signal about company fundamentals.

Insider Transaction Report

Form 4
Period: 2026-04-28
Roper Martin
DirectorChief Executive Officer
Transactions
  • Exercise/Conversion

    Common Stock

    2026-04-28$10.18/sh+25,000$254,450323,484 total
  • Sale

    Common Stock

    [F1]
    2026-04-28$51.13/sh25,000$1,278,250298,484 total
  • Exercise/Conversion

    Common Stock

    2026-04-29$10.18/sh+20,544$209,097319,028 total
  • Sale

    Common Stock

    [F1][F2]
    2026-04-29$59.35/sh20,544$1,219,245298,484 total
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    [F6]
    2026-04-2825,000350,214 total
    Exercise: $10.18Exp: 2029-09-19Common Stock (25,000 underlying)
  • Exercise/Conversion

    Non-Qualified Stock Option (Right to Buy)

    [F6]
    2026-04-2920,544329,670 total
    Exercise: $10.18Exp: 2029-09-19Common Stock (20,544 underlying)
Holdings
  • Common Stock

    [F3]
    (indirect: by Chris Roper FT)
    215,631
  • Common Stock

    [F4]
    (indirect: by Peter Roper FT)
    216,131
  • Common Stock

    [F5]
    (indirect: by Thomas Roper FT)
    216,131
  • Common Stock

    (indirect: By Spouse)
    41,200
  • Non-Qualified Stock Option (Right to Buy)

    [F6]
    Exercise: $10.18Exp: 2031-01-11Common Stock (40,950 underlying)
    40,950
  • Non-Qualified Stock Option (Right to Buy)

    [F7]
    Exercise: $15.00Exp: 2031-10-21Common Stock (298,507 underlying)
    298,507
  • Non-Qualified Stock Option (Right to Buy)

    [F8]
    Exercise: $16.91Exp: 2033-03-10Common Stock (46,875 underlying)
    46,875
  • Non-Qualified Stock Option (Right to Buy)

    [F6]
    Exercise: $16.91Exp: 2033-03-10Common Stock (185,133 underlying)
    185,133
  • Non-Qualified Stock Option (Right to Buy)

    [F9]
    Exercise: $26.18Exp: 2034-03-04Common Stock (62,743 underlying)
    62,743
  • Non-Qualified Stock Option (Right to Buy)

    [F10]
    Exercise: $32.78Exp: 2035-03-03Common Stock (70,715 underlying)
    70,715
Footnotes (10)
  • [F1]The sales of shares of common stock reported were effected pursuant to a Rule 10b5-1 trading plan.
  • [F10]The stock option vests in four equal annual installments beginning on March 3, 2026.
  • [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $56.68 to $60.50, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F3]These shares are held by the Christopher G. Roper Exempt Family Trust.
  • [F4]These shares are held by the Peter S. Roper Exempt Family Trust.
  • [F5]These shares are held by the Thomas L. Roper Exempt Family Trust.
  • [F6]The stock option is fully vested and currently exercisable.
  • [F7]The stock option vests in four equal annual installments beginning on November 27, 2022.
  • [F8]The stock option vests in four equal annual installments beginning on March 10, 2024.
  • [F9]The stock option vests in four equal annual installments beginning on March 4, 2025.
Signature
/s/ Alison Klein, attorney-in-fact for Martin Roper|2026-04-30

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT